Jennifer Fulk
Jennifer Fulk and the Company have mutually agreed that Ms. Fulk will step down from her position as Chief Financial Officer, effective as of May 20, 2024.
Highest-materiality recent filing
Talkspace completes $870.6M acquisition by Universal Health Services; shares converted to $5.25 cash
Each Talkspace share converted to $5.25 cash; total consideration ~$870.6M, funded via UHS credit facilities.
Talkspace stockholders vote 73.48% to approve UHS acquisition; advisory compensation not approved
Approved merger with Universal Health Services (UHS) via 73.48% of outstanding shares voted in favor.
Universal Health Services to acquire Talkspace for $5.25 per share, ~$835M enterprise value
Talkspace generated $229M revenue in 2025; ~6,000 providers, over 1.6M therapy sessions.
Talkspace acquired by Universal Health Services for $5.25 per share in cash
Talkspace (TALK) enters definitive merger agreement with UHS (UHS); all outstanding shares converted to $5.25 cash.
Talkspace Q4 revenue $63M (+29% YoY), net income $4.8M; FY25 EBITDA up 127% to $15.8M
Q4 revenue $63.0M (+29% YoY), net income $4.8M, adjusted EBITDA $6.6M (+147% YoY).
Talkspace Q3 revenue $59.4M (+25% YoY); raises FY 2025 revenue guidance to $226-230M
Revenue of $59.4M, up 25% YoY; Payor revenue grew 42% YoY while Consumer revenue fell 23%.
Talkspace acquires AI-powered peer support platform Wisdo Health
Wisdo Health is a clinically-proven AI-powered social health and peer support platform.
Talkspace Q2 revenue $54.3M (+18% YoY); adjusted EBITDA $2.3M; guides FY $220-235M
Revenue $54.3M, up 18% YoY; Payor revenue +35%, Consumer revenue -32%.
Talkspace Q1 2025 revenue $52.2M (+15% YoY); net income $0.3M vs ($1.5M) loss
Revenue $52.2M (+15% YoY) driven by 33% Payor revenue growth; Consumer revenue down 32%.
Talkspace Q4 revenue up 15% to $48.7M; net income $1.2M; guides 2025 rev $220M-$235M
Full-year 2024 revenue $187.6M (+25% YoY); net income $1.1M vs $(19.2)M loss in 2023.
Talkspace reports Q3 2024 net income of $1.9M; revenue up 23% to $47.4M
Revenue $47.4M (+23% YoY); payor revenue +45%, DTE +17%, consumer -30%.
Talkspace Q2 revenue up 29% YoY to $46.1M; reports positive Adj. EBITDA of $1.2M
Revenue $46.1M (+29% YoY); Payor revenue up 62% YoY; DTE revenue up 20% YoY.
Talkspace appoints Ian Harris as CFO, Jennifer Fulk steps down
Jennifer Fulk steps down as CFO effective May 20, 2024; no disagreements; will assist transition.
Talkspace reports first profitable quarter, revenue up 36% YoY to $45.4M
Revenue $45.4M (+36% YoY); Payor revenue surged 92%, consumer revenue fell 29%.
Talkspace Q4 revenue up 40% to $42.4M; net loss narrows; guides 2024 EBITDA positive
Q4 payor revenue surged 138% YoY; total revenue $42.4M (+40% YoY).
Talkspace Q4 net loss narrows to $1.3M; announces $15M share repurchase
Q4 revenue $42.4M (+40% YoY); Payor revenue up 138% YoY.
Talkspace Q3 revenue $38.6M (+32% YoY), net loss improves 75% to $4.4M
Revenue $38.6M (+32% YoY); B2B payor revenue up 79%, consumer revenue down 32%.
Talkspace Q2 revenue up 19% YoY to $35.6M; net loss narrows 80%; raises FY guidance
Revenue $35.6M (+19% YoY); B2B payor revenue up 135% YoY to drive growth.
Talkspace gets 180-day bid price extension; listing moved to Nasdaq Capital Market
Received Nasdaq extension until Nov 13, 2023 to regain $1.00 minimum bid price for 10 consecutive days.
Talkspace Q1 revenue $33.3M (+11% YoY); net loss narrows; raises FY guidance
Revenue $33.3M (+11% YoY); B2B revenue up 71%; B2B sessions +90% to 171.7k.
Talkspace files Delaware Section 205 petition to validate charter and stock issuances
Filed petition on March 3, 2023 to validate 2021 charter after potential class-vote defect under Boxed ruling.
Talkspace Q4 revenue $30.2M, net loss $18.3M; guides FY23 rev $125-135M
Q4 2022 revenue $30.2M (+4% YoY); FY 2022 revenue $119.6M (+5% YoY).
Talkspace receives Nasdaq notice for bid price below $1.00; 180-day cure until May 17, 2023
Nasdaq notified Talkspace that its common stock bid price closed below $1.00 for 30 consecutive business days.
Talkspace appoints Dr. Jon R. Cohen as CEO; Braunstein remains Chairman
Dr. Jon R. Cohen named CEO effective Nov. 9, 2022, replacing interim CEO Doug Braunstein.
Talkspace Q3 revenue up 11% to $29.3M; net loss widens to $18M
Total revenue $29.3M (+11% YoY); B2B revenue surged 117% while B2C declined 33%.
Talkspace Q2 revenue down 4% to $30M; B2B revenue up 47% but B2C down 28%, net loss narrows to $23M
Q2 revenue $29.8M (-4% YoY); B2B revenue grew 47%, B2C dropped 28%.
Talkspace grants equity award of 640k options + 1.65M RSUs to interim CEO
Non-qualified stock option for 640,000 shares of common stock granted to Douglas Braunstein.
Talkspace Q1 revenue $30M (+11% YoY); net loss widens to $20.4M
Revenue $30.2M, up 11% YoY; B2B revenue grew 50% partially offset by 7% B2C decline.
Talkspace reports FY 2021 revenue up 49% to $114M, net loss widens to $63M
Revenue $113.7M (+49% YoY); B2B eligible lives up 75% to 69M.
Talkspace corrects B2B eligible lives: June 30 from 71.9M to 55.0M, Sept 30 from 75.3M to 56.6M
Prior B2B eligible lives overstated by ~24-25%: June 30 revised to 55.0M (from 71.9M), Sept 30 to 56.6M (from 75.3M).
Talkspace co-founders Oren and Roni Frank step down; Chairman Braunstein named Interim CEO
Oren Frank (CEO) and Roni Frank (Head of Clinical Services) resign from roles and board, effective immediately.
Talkspace Q3 revenue $26.4M (+23% YoY) misses; adjusted EBITDA loss widens to $20.8M
Net revenue $26.4M (+23% YoY) but missed expectations due to lower B2C customers and $2.8M non-cash reserve adjustment.
Talkspace Q2 revenue $31M (+73% YoY), net loss $30.4M; reaffirms FY21 guidance
Net revenue $31.0M, up 73% YoY from $17.9M; gross margin 62.2% vs 68.8%.
Jennifer Fulk and the Company have mutually agreed that Ms. Fulk will step down from her position as Chief Financial Officer, effective as of May 20, 2024.
Effective as of May 20, 2024, the Board has appointed Ian Harris as Chief Financial Officer to succeed Ms. Fulk.
On December 1, 2023, after reviewing the qualifications, experience and independence of Ms. Liat Ben-Zur and Ms. Swati Abbott (the “New Directors”) and, after recommendation by the Nominating and Corporate Governance Committee, the Board appointed the New Directors via unanimous written consent.
On December 1, 2023, after reviewing the qualifications, experience and independence of Ms. Liat Ben-Zur and Ms. Swati Abbott (the “New Directors”) and, after recommendation by the Nominating and Corporate Governance Committee, the Board appointed the New Directors via unanimous written consent.
Mr. Douglas Braunstein, who had been serving as Interim Chief Executive Officer since November 2021, stepped down from such position as of the time at which Mr. Cohen’s appointment became effective.
the Board of Directors (the “Board”) of Talkspace, Inc. (the “Company”) appointed Dr. Jon R. Cohen to the position of Chief Executive Officer of the Company, effective as of November 9, 2022.
On October 17, 2022, Samara Braunstein provided notice to the board of directors of Talkspace, Inc. (the “ Company ”) that she will be departing from her role as Chief Marketing Officer of the Company, effective immediately.
the Board appointed Mr. Michael Hansen, as a Class II director, effective immediately, to fill the vacancy created by Mr. Berg’s resignation.
Charles Berg, a member of the Board of Directors (the “Board”) of Talkspace, Inc. (the “Company”), resigned as director of the Company effective as of the 2022 Annual Meeting of Stockholders of the Company.
On September 6, 2022, Charles Berg, a member of the Board of Directors (the “Board”) of Talkspace, Inc. (the “Company”) , notified the Board of his decision to resign as director of the Company effectively as of the 2022 Annual Meeting of Stockholders of the Company.
On November 22, 2021, Talkspace, Inc. (the "Company") announced the resignation of Mark Hirschhorn, President and Chief Operating Officer, effective immediately.
On November 15, 2021, Oren and Roni Frank, co-founders of Talkspace, Inc. (the “Company”) announced that they will be departing from their respective roles as Chief Executive Officer and Head of Clinical Services and will step down as members of the Company’s Board of Directors (the “Board”), effective immediately.
Max materiality 1.00 · Median 0.70 · Most common event earnings